Bimekizumab maintains long term safety profile in psoriatic arthritis and axial spondyloarthritis, shows study Dr Riya Dave24 March 2026 9:00 PM ISTLong-term extension studies have shown that bimekizumab (Bimzelx) maintains a consistent safety profile for 2 years or more in patients with psoriatic...
FDA Approves Deucravacitinib for Active Psoriatic Arthritis Dr. Kamal Kant Kohli16 March 2026 8:15 PM ISTThe U.S. Food and Drug Administration has approved Deucravacitinib (Sotyktu) for the treatment of adults with Psoriatic Arthritis. This oral drug is a...
From Psoriasis to Psoriatic Arthritis: Strategies for Early Risk Modification Dr. Bhumika Maikhuri9 March 2026 11:15 AM ISTKey Summary The transition from psoriasis to psoriatic arthritis (PsA) is driven by several modifiable risk factors, including obesity, severe...
Psoriatic Arthritis Strongly Linked to Metabolic Syndrome, finds study Jacinthlyn Sylvia25 Feb 2026 8:30 PM ISTA new meta-analysis published in the recent issue of Clinical Rheumatology journal revealed that metabolic syndrome (MetS) is significantly more...
USFDA Accepts Dr Reddy's BLA for Interchangeable Orencia Biosimilar Parthika Patel21 Feb 2026 1:00 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd. has received acceptance from the U.S. Food and Drug Administration to review its 351(k) Biologics License...
Ixekizumab and Tirzepatide combo Improves PsA Control and Weight Loss, suggests study Dr. Kamal Kant Kohli13 Jan 2026 8:15 PM ISTThe TOGETHER-PsA study shows that combining ixekizumab with tirzepatide leads to significantly better psoriatic arthritis disease control and greater...
Early DMARD Initiation Improves Disease Control in Psoriatic Arthritis, Suggests Study Medha Baranwal29 Dec 2025 8:15 PM ISTUSA: Researchers have found in a new study that patients with psoriatic arthritis (PsA) were more likely to achieve minimal disease activity (MDA)...
Targeting IL-17A may Modify Risk Factors for Psoriatic Arthritis in Patients with Psoriasis Dr. Bhumika Maikhuri19 Dec 2025 11:00 AM ISTOverviewIn this short video, Dr. Paolo Gisondi, MD, Associate Professor of Dermatology and Venereology at the University of Verona, Italy, discusses...
Real-World Evidence in Psoriatic Arthritis: PRO-SPIRIT Study Dr. Garima Soni25 Nov 2025 11:45 AM ISTIn the video, Dr. Nicola J. Gullick, a Consultant Rheumatologist in Coventry and one of the investigators on the PRO-SPIRIT study, provides an...
Biocon Pharma gets USFDA nod for arthritis drug Tofacitinib ER Ruchika Sharma19 Nov 2025 11:15 AM ISTBengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval from the U.S...
